December 2021 Vol 12, No 12

Caring for Sexual and Gender Minority Patients: What Factors Explain Self- Reported Competence Among Healthcare Professional Students?
Mandi Pratt-Chapman, MA, PhD, HON-OPN-CG, Jennifer Potter, MD
December 2021 Vol 12, No 12
Lesbian, gay, bisexual, transgender, queer, and intersex (LGBTQI) people—broadly included within the umbrella of “sexual and gender minorities” (SGM)—have unique health and healthcare needs. SGM youth experience higher rates of family rejection, increased use of tobacco and other substances, more bullying, and higher suicide rates.
Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab versus Chlorambucil plus Obinutuzumab for Treatment-Naive Chronic Lymphocytic Leukemia (ELEVATE-TN)
P Walker , JP Sharman, W Jurczak, T Munir, V Banerji, S Coutre, JA Woyach, G Salles, WG Wierda, P Patel, MH Wang, U Emeribe, E Flood, JC Byrd, P Ghia
December 2021 Vol 12, No 12
Nursing Experience in Patients with Chronic Lymphocytic Leukemia Receiving First-Line Ibrutinib: Up to 7 Years of Follow-Up from the Phase 3 RESONATE-2 Study
Cara McGowan, NP, Jillian Settlemire, RN, Anita Szoke, MD, Gabriel Krigsfeld, PhD, Steven Coutre, MD, Paul Barr, MD
December 2021 Vol 12, No 12
Mapping the PIK3CA-Related Overgrowth Spectrum Patient and Caregiver Journey Using a Patient-Centered Approach
Dawn Aubel, EdD, MPH, APNc, Lara Rodríguez-Laguna, PhD, Kristen Davis, BS, Mellenee Finger, Robin Vlamis, MPH, CHES, Craig Johnson, DO
December 2021 Vol 12, No 12
Impact of Age on Efficacy and Safety of Relugolix: A Subgroup Analysis from the Randomized, Phase 3 HERO Study versus Leuprolide in Men with Advanced Prostate Cancer
Michael S. Cookson, MD, MMHC, Neal D. Shore, MD, Daniel J. George, MD, Hideyuki Akaza, MD, Daniel R. Saltzstein, MD, Ronald Tutrone, MD, Alberto Bossi, MD, Bruce Brown, MD, Bryan Selby, MS, Sophia Lu, PhD, Jackie Walling, MBChB, PhD, Bertrand Tombal, MD, PhD, Fred Saad, MD
December 2021 Vol 12, No 12
Expert Guidance Based on Clinical Experience of Tepotinib Side Effect Management in Patients with NSCLC Harboring MET Exon 14 Skipping
Terri Alexander, MSc
December 2021 Vol 12, No 12
Expanding the Way We Screen for Cancer: A Path to a Multicancer Early Detection Test
Tomasz M. Beer, Charles H. McDonnell, III, Lincoln Nadauld, Minetta C. Liu, Eric A. Klein, Robert Reid, Catherine R. Marinac, Karen C. Chung, Margarita Lopatin, Eric T. Fung, Deborah Schrag
December 2021 Vol 12, No 12
Characterization of Adverse Reactions in Patients with Advanced Endometrial Cancer (aEC) Receiving Lenvatinib + Pembrolizumab (Study 309/KEYNOTE-775): Nurse Roles in Patient Education and Adverse-Reaction Management
Giorgia Villa, Nicoletta Colombo, Melissa Zale, Min Ren, Lea Dutta, Vicky Makker, Vania Hom
December 2021 Vol 12, No 12
Characterization and Management of Gastrointestinal and Skin Toxicities with Mobocertinib in EGFR Exon 20 Insertion+ Non–Small-Cell Lung Cancer
Kelly Goodwin, NP
December 2021 Vol 12, No 12
Adherence to Injectable and Oral Hormone Therapies in Advanced Prostate Cancer as Measured by Proportion of Days Covered
Tao Jiang, Robert Dufour, Eddie Li, Janis Pruett
December 2021 Vol 12, No 12
AONN+: Looking Forward with Optimism to 2022
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
December 2021 Vol 12, No 12
Here we are at the end of another rather unusual year. As the pandemic continues, we’ve had to adapt our oncology practices, our personal lives, and our professional organizations to function in the safest way possible.
Results from the Final Analysis of the Phase 3 iNNOVATE Study: Nursing Experience with Patients Receiving Ibrutinib plus Rituximab for Waldenström’s Macroglobulinemia
Kate Mimken, NP-C, Tolu Adewuya, MMedSci, PhD, CCRC, Bernhard Hauns, MD, PhD, Israel Arango-Hisijara, MD, Leonard T. Heffner, MD, Jeffrey V. Matous, MD
December 2021 Vol 12, No 12
The Clinical Utility of DCISionRT on Radiation Therapy Decision-Making in Patients with Ductal Carcinoma in Situ Following Breast-Conserving Surgery
Troy Bremer, PhD, Charles Cox, MD, Pat Whitworth, MD, Rakesh Patel, MD, Steve Shivers, PhD
December 2021 Vol 12, No 12
The Oncology Nurse’s Perspective on Recently Reported SOLAR-1 Findings
Jaimie Heldstab, FNP-BC, AOCNP, Janie A. Metsker, RN, BSN, CN-BN, ONN-CG
December 2021 Vol 12, No 12
Doctors Join the Climate Lobby
December 2021 Vol 12, No 12
Don’t they know that poverty kills far more people than heat does?
The Political Raid on Future Cures
December 2021 Vol 12, No 12
The Democratic price controls on drugs would be a historic tragedy.
Partisan Science in America
Gary Saul Morson
December 2021 Vol 12, No 12
Scientists corrode public trust when they pretend to have authority on social and political matters.
Loading More Articles

Results 1 - 17 of 17

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
SUBSCRIBE

Contact Us | Editorial Board

© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512